Traditional drug dealers are still formidable competitors in U.S. states where cannabis is legal. Governments planning for huge tax windfalls and investors expecting rapid market-share gains have to adjust to a slower burn.

Legalization of cannabis in California, currently the world’s largest recreational pot market, has been bumpy. Restrictions on adult use were lifted in January 2018 and the Californian legislature projected $1 billion in annual state and local taxes from cannabis sales within a few years. …

Read FULL Story in the Wall Street Journal


Those chosen have until Aug. 28 to pay licensing fees, and provide a letter of credit for $50K to regulator


Jordan Kanygin , Video Journalist – Published Thursday, July 25, 2019

Calgary’s Folk Music Festival is celebrating its 40th birthday in 2019 with something that its never had before, a legal cannabis area.

In what is a first for a public event in Calgary, cannabis users will be able to smoke in a designated area at the back of the festival grounds.

“Given our audience, I think it made sense,” said Kerry Clarke, the festival’s artistic director.

“It made sense to accommodate some people who like to smoke, but to also accommodate the people who don’t like to be around it.”

Consumption will be allowed in the small fenced-in area, which is covered with signs indicating tobacco smoke and any other drug than cannabis is not allowed.

Folk fest worked with Alberta Gaming, Liquor and Cannabis (AGLC) and Calgary bylaw to make sure the area complies with provincial and city rules. Extra security guards had to be hired to watch the consumption area.

“It’s a place for people to go and safely consume, but there are a lot of restrictions to it,” Clarke said, pointing out it’s nowhere near the festival’s beer garden.

Clarke says festival organizers plan to make a decision on the cannabis site at future festivals based on feedback from concert-goers.

Folk fest welcomes about 53,000 people over the course of the weekend, with about 12,000 people per day. It runs Thursday through Sunday.

Story from CTV


Elianna Lev – Yahoo Canada News – 

Now that Canadians have access to legalized cannabis, a Vancouver-based activist is focused on administering another substance that’s said to have both medicinal and recreational benefits: magic mushrooms.

Dana Larsen is behind the Medicinal Mushroom Dispensary, an online shop that sells microdoses of psilocybin, the psychoactive component in magic mushrooms. Larsen explains that the shop sells 25 ml, 50 ml and 100 ml doses – about five to 10 per cent of what you’d take if you wanted to experience hallucinations.

“The idea behind microdosing is to get the medical benefits of mushrooms without the intensity or psychoactivity you’d get in a bigger dose,” he tells Yahoo Canada. “You use it a few times a week for a couple of months. It’s anti-addictive – you can’t take it everyday or it’ll stop working.”

While magic mushrooms are illegal in Canada, psilocybin is being studied for its potential to treat mental illnesses like anxiety, depression, and PTSD, amongst others.

In the U.S., Denver and Oakland have decriminalized magic mushrooms. In Canada, there’s currently no therapeutic products containing psilocybin that have been approved.

Despite this, Larsen intends to open a storefront in Vancouver, similar to the one he opened for cannabis several decades ago. People interested in ordering from his online store must submit a notice of diagnosis for one of the ailments psilocybin is believed to help with, along with photo ID. The dispensary only sells to customers within Canada.

Larsen says Vancouver police are aware of his activities but he doesn’t expect much engagement with them since they’re busy focused on more pressing matters, like the fentanyl crisis.

“I don’t think the VPD has much interest in spending the time and resources to come after me when I’m only selling microdoses to people with a confirmed medical need,” he says, adding that Health Canada and other levels of enforcement could potentially pose challenges in the future.

“Hopefully no one out there thinks microdosing is really an issue to bother cracking down on me on this” he says. “But there is definitely a risk involved.”

The future of psilocybin in Canada

Jordan Donich, a Toronto-based criminal lawyer, says in order for magic mushrooms to go the same route as cannabis, it will need to get political support.

“That’s how cannabis became legal,” he tells Yahoo Canada. “That’s what has to come from the grassroots of it, if it’s going to be legal.”

He says if there is political support to legalize magic mushrooms, the process will have to shadow the same process that cannabis went through to be fully legalized for recreational and medicinal consumption.

“It will probably have to follow the same blueprint that cannabis went through,” he says. “Not only for consumption but all the other ways it can impact the laws, like driving.”

Donich says that if a substance is proven to have medicinal benefits, it’s quite likely that it could be legally consumed for that purpose. The question is, are we going to have the same kind of public acceptance and accessibility as we do with cannabis?

“Then we have to ask ourselves from a policy perspective, is it a slippery slope,” he asks. “From a broader, policy objectives: What does it mean for crime or productivity?”

If magic mushrooms are the next substance to be legalized, voters are going to have to put a candidate in power for it to happen, Donich says.

“Because if that’s what the voters want, that’s the way it should be and that’s where it starts,” he says.

Larsen says some activists will be in court later this year to challenge psilocybin prohibition under Section 56 of the controlled drug act, which allows people to be exempt from any of the drug laws, and is typically used for research purposes.

“It will take years but I expect that this legal challenge will lead to a change in the law, especially for microdoses, when there’s no psychoactivity,” he says. “I find it hard to see a lot of opposition to that.”

Story in Yahoo News




Jon Rumley – Senior Front Page Editor, HuffPost Canada


Mike Bebernes Editor – Yahoo News 360 – J

What’s happening: On Tuesday, Illinois became the 11th state to legalize recreational marijuana use. The legislation also includes a provision that will allow nearly 800,000 people to have existing offenses for buying or selling marijuana scrubbed from their records.

Several other states that have legalized pot have created similar methods for pot-related convictions to be either reduced in severity or cleared completely. There are roughly 600,000 marijuana arrests a year in the United States.

Why there’s debate: Proponents of these measures argue that people shouldn’t continue to be punishedfor having committed acts that are no longer illegal in their states. Some also make the case for expunging records on social justice grounds, given the significant racial imbalance among those who are convicted of drug crimes.

Others believe expungement makes economic sense, because it alleviates the expense of incarceration and makes it easier for former offenders to join the workforce and contribute to the tax base. Those who were punished when pot was illegal, some say, are left out of the booming marijuana industry, since most states that have legalized marijuana bar anyone with a criminal record from participating in the legal weed business.

Opponents of the idea argue that the convictions should stand because the offenses were crimes at the time they were committed. There is also, of course, significant resistance to marijuana legalization in general.

What’s next: Legal marijuana use seems likely to spread to even more states in the near future. Illinois was the first state to pass full legalization through the legislative process, rather than passing the measure through voter referendum. Lawmakers in states that are considering bills to legalize or decriminalize marijuana use, such as New York and New Jersey, have made expungement of pot offenses a core part of the debate.


Marijuana convictions can have a severe impact on people’s lives

“No one should underestimate how much even the most minor of misdemeanor convictions — including marijuana or trespassing or any kind of conviction — can affect someone’s ability to get a job, to get housing and to function fully in society.” — American University law professor Jenny Roberts to NPR

It’s unfair for people to still be punished by old laws when others are able to profit off new ones

“Before a single Wall Street-loving yacht owner makes another dollar off a demonized plant with long-known medicinal properties, every single person who was thrown into the criminal justice system for enjoying it should get their lives back as much as possible.” — Simon Moya-Smith, NBC News

Marijuana shouldn’t be legal

“Marijuana’s risks are different from opioids’, but they are no less real. Let’s remember that hard truth as we listen to promises that allowing the use of this drug will do no harm.” — Alex Berenson, New York Times

Pot arrests hold people back from making economic progress

“Once arrested, men and women are ensnared in a Kafkaesque system that critically compromises their ability to succeed and participate in society. An arrest record can prevent them from obtaining employment, housing, student loans, and litany of other collateral consequences.” — Khalil Cumberbatch, New York Daily News

Clearing records would help fix the racially imbalanced impact of the war on drugs

“Marijuana use in the U.S. is roughly equal among blacks and whites, yet, on average, blacks are nearly four times as likely to be arrested for marijuana possession.” — Kevin Aldridge, Cincinnati Enquirer

Racial inequities in criminal justice won’t be fixed by changing marijuana laws

“The research bolstering the argument that the disparities reflect discriminatory law enforcement is squishy at best, as is the claim that legalization in other states has made a substantial difference in reducing the disparities.” — editorial, Asbury Park Press

Past marijuana convictions are causing people of color to be left out of the growing legal cannabis industry

“Marijuana legalization and the businesses that profit from it are accelerating faster than efforts to expunge criminal records, and help those affected by them participate in the so-called ‘Green Boom.’ And the legal cannabis industry is in danger of becoming one more chapter in a long American tradition of disenfranchising people of color.” — Jenni Avins, QZ

Clearing a conviction should happen automatically or be easy

“The problem is the mechanism for getting one’s marijuana record expunged varies from state to state, and in most places it ranges from burdensome to nearly impossible.” — C.J. Ciaramella, Reason

Clearing pot convictions would not make a meaningful difference in incarceration levels

“It’s fair to say that marijuana prohibition — and even the war on drugs more broadly — is not the major driver of mass incarceration.” — German Lopez, Vox

Yahoo 360






Dr Robin Carhart-Harris, head of psychedelic research at Imperial College, London, explains that psilocybin is similar to LSD, but weaker, and mimics serotonin activity in the brain. It reduces brain activity in information transfer centres such as the thalamus, which sits just above the brainstem. The thalamus tells the brain what movement and sensations it is detecting. Whatever the mechanism, shrooms can make you euphoric, at one with the world and searingly insightful. Colours and geometric patterns may be vivid. Carhart-Harris says magic mushrooms are not really recreational drugs: “It’s more a drug of self-exploration,” he says. The environment, though, is essential to having a positive experience – people need space, a “sober sitter” to take care of them – and they may need reassurance that they are not going mad. Carhart-Harris prefers the term “challenging experience” over “bad trip”: mushrooms can cause anxiety, panic and depersonalisation – but studies show people still value the experience as meaningful.

Studies do not show increased mental health problems from habitual use – unlike the effects of cocaine or cannabis. A BMJ article by psychiatrist James J H Rucker argues that psychedelic drugs may actually help depression and that there is no association with psychosis. A paper in science journal PLoS One found no evidence of flashbacks (such as hallucinations or panic attacks) from sole mushroom use. Mushrooms aren’t habit forming and are far less toxic to our internal organs than heroin or cocaine. However, you should not take them as they are against the law, and this article is not promoting their use in any way. I am also keen to point out that there is a big risk of accidentally taking the wrong kind of mushroom – psilocybin mushrooms are safe, but others, such as Amanita muscaria, are toxic and can destroy your kidneys or can even be fatal.

Carhart-Harris researches into the benefits of psychedelic drugs on depression, and says that most experiences on mushrooms are positive – people generally know they have taken something and that they are not going out of their minds. The effect is different, he says, to when people unknowingly take these drugs. And while mushrooms are illegal for everyone, young people in particular should stay away. “They are not for teenagers,” he warns. “They make you psychologically vulnerable and you need the capacity to make sense of the experience.”

The Guardian


As cannabis legalization spreads across the globe, another mind-altering drug is trying to follow in its tracks: magic mushrooms.

Denver voted in May to decriminalize the fungus that contains psilocybin, a psychedelic compound popularized by ’60s counterculture. Oakland, Calif., followed Denver’s lead a few weeks later and Oregon is trying to get a similar measure on the ballot for 2020.

Advocates say mushrooms have untapped medical potential that could be as big as cannabis, particularly for treating depression and addiction. The U.S. Food and Drug Administration granted “breakthrough therapy” status in October to Compass Pathways Ltd. to test the drug for treatment-resistant depression, expediting the development process. The London-based company says it’s now proceeding with a large-scale clinical trial in Europe and North America.

In recent years, researchers at New York University found psilocybin caused a “rapid and sustained” reduction in anxiety and depression in patients with life-threatening cancer. And psychiatrists at Johns Hopkins University discovered mushrooms can help people quit smoking. Another study found the psychedelic can also help with alcohol dependence.

“The medical and therapeutic applications are becoming incontrovertible in a world where depression is one of the most commonly diagnosed conditions,” said Ronan Levy, a former executive at Aurora Cannabis Inc. and co-founder of Toronto-based Field Trip Ventures, a startup focused on therapeutic psychedelics including mushrooms.

Levy believes it’s only a matter of time before others — including many former cannabis executives — realize the potential of psychedelics and start to look for investors. Interest is already starting to grow in some fields. Sanjay Singhal, the founder of, is funding research into psilocybin and other psychedelics, including a planned study into microdosing at the University of Toronto’s Center for Psychedelic Studies.

Unlike cannabis, however, research into psilocybin’s medical applications is limited by the fact that the drug remains illegal virtually everywhere. Denver, for example, has made personal use and possession of mushrooms “the city’s lowest law-enforcement priority” but selling and distributing the drug is still illegal.

This has been challenging for psychotherapists like Bruce Tobin, a registered clinical counsellor in Victoria who specializes in treatment of anxiety, depression and emotional trauma.

Tobin has asked the Canadian government for what’s known as a Section 56(1) exemption, which gives researchers and physicians access to substances that are prohibited under the country’s Controlled Drugs and Substances Act. He believes there are about 3,000 people in Canada suffering from end-of-life distress who aren’t responding to other depression treatments.

“This is a group for whom it’s literally true that they have nothing left to lose, and our argument is that for these particular people, psilocybin counts as a reasonable medical treatment for them right now,” even before advanced clinical trials have been completed, he said.

Tobin doesn’t expect to be successful but is prepared to go to court to fight the decision, much the same way marijuana advocates did in the landmark cases that led to medical pot legalization in 2001.

Although he sees the cannabis rulings as setting “extremely strong legal precedence” for psilocybin, he doesn’t want to see mushrooms follow the same path to legalization as pot. The high from mushrooms lasts longer and can be much more intense than cannabis and sometimes accompanied by hallucinations, nausea and the risk of a “bad trip.”

“I’m a little uneasy that there are many entrepreneurs in Canada that see psilocybin as the next big thing, and I want to discourage that,” Tobin said. He sees the drug as one part of an ongoing psychotherapy process that should only be done under the supervision of a specialist, and believes some people should never take psychedelics at all.

“I don’t want this to sound too literal, but between cannabis and psychedelics, it’s sort of the difference between conventional and nuclear weapons,” he said. “I don’t see psilocybin as something that will become legal in Canada or necessarily ever should be.”

Toronto Star


New cannabis products — like edibles, beverages, topicals and extracts — will be for sale legally in Canada in mid-December.

Regulations will come into effect on Oct. 17, and the products will be available two months later, Radio-Canada has learned.

Details on the final regulations and timeline will be released Friday by Health Canada.

It’s expected a limited selection of products will appear gradually in physical or online stores. Federal licence holders must provide 60 days notice to Health Canada of their plan to sell the products, and distributors and retailers authorized by provinces or territories will need time to purchase and obtain the new products and make them available for sale.

When dried cannabis became legal for recreational use last October, Ottawa continued its consultations on rules for edibles and other products. The consultations ended in February. Ottawa indicated at the time that regulations on cannabis edibles and concentrates would come into effect on Oct. 17, 2019.

The new regulations will give authorized distributors and retailers access to three new classes of cannabis products:

  • Edibles (candy, baked goods).
  • Cannabis extracts.
  • Cannabis “topicals” (ointments, oils, makeup).

Greg Boone, CEO of the P.E.I.-based cannabis firm Dosecann, said he’s excited the regulations have been finalized. For the past three years, he said, his company has been preparing for this announcement.

“That will get us into the full production of these edibles or value-added products,” he said. “And the goal is to build inventory to be able to satisfy the market that we believe exists across the country for these types of products.

“Things such as vape pens, potentially topicals, and edibles such as chocolates and potentially gummies. Those types of products will eventually be rolled out.”


Cannabis-infused alcoholic beverages and cannabis products containing tobacco, nicotine or caffeine will be prohibited.

Health Canada will maintain strict rules on labelling to prevent companies from making the products more attractive to young people.

The packaging and labelling must have a clear cannabis symbol, a health warning listing the product’s tetrahydrocannabinol (THC) and cannabidol (CBD) content, limited use of logos and colours and child-resistant packaging.

Critics have voiced the fear that edibles resembling candy might be too attractive to children. The Task Force on Cannabis Legalization and Regulation recommended a ban on any cannabis product that could appeal to children — such as those resembling popular food items or that are packaged to look like candy.


Once the new regulations are in place, cannabis companies will be able to offer concentrates such as resin or cannabis oil for vaping. Vaping products with scents that could appeal to children would not be permitted.

Restaurants will not be allowed to serve food containing cannabis.

The market for this next-generation category of cannabis products is forecast to be worth about $2.7 billion annually,  according to a Deloitte report released earlier this month.

The Deloitte report said about 50 per cent of edibles users surveyed said they planned to consume cookies, brownies or chocolate at least once every three months.

With anticipated demand so high, the government’s plan to roll out regulations in October gives the industry time to build inventory.

Since cannabis was first legalized last year, supply shortages have persisted in many provinces. The introduction of edibles could drag out those shortages for years.

Anticipating robust demand, companies like Dosecann have been stockpiling cannabis for use in research and in edible products.

“We’re holding back or acquiring product basically to turn into oil, which we will put into our value-added products, where we see greater potential for profitability,” Boone said.

He said he expects his company of 45 employees will more than double in size by the end of the year.


You may not see them popping up in dispensaries yet, but Oakland just allowed the use of “magic mushrooms” and other natural psychedelics.

On Tuesday, Oakland’s City Council voted unanimously to decriminalize the use of ‘shrooms and other natural psychedelic or hallucinogenic drugs, including cacti, becoming the second city in the country to take this step.
The drugs still aren’t necessarily legal, but the resolution means police cannot impose criminal penalties for using the natural drugs or use any city funds to investigate or enforce the criminal penalties. Even people currently being prosecuted for these kinds of drugs are now off the hook, according to the resolution.
Denver was the first city to enact this kind of ordinance, in May. But Oakland’s goes further: where Denver’s ordinance was focused on ‘”magic mushrooms” — which contain psilocybin — Oakland is decriminalizing any plant or fungi that has hallucinogenic or pschedelic properties. That’s a first for any US city, but it doesn’t apply to drugs such as LSD or MDMA, which are synthetic.


The resolution was introduced by City Council member Noel Gallo and backed by Decriminalize Nature Oakland, a group that promotes natural psychedelics for health benefits.
In Gallo’s agenda report, he referenced the use of peyote in Native American communities. The evening of the resolution’s signing, over 100 people testified about the way natural psychedelics have helped them.
Gallo is from a Native American family, and he told CNN these kinds of natural psychedelics were familiar to him while growing up in Oakland.
“We didn’t go to Walgreens for medication,” he said. “My grandma had plants in her backyard that would heal us.”
He also said that implementing the resolution would reduce the resources Oakland police use in investigating these crimes, so they could focus on more pressing matters in the city instead.


The push for decriminalizing these natural psychedelics comes following research that they have health benefits, notably for people experiencing mental health issues, such as depression.
Last year, researchers at Johns Hopkins University found that psilocybin, which is in ‘shrooms, have medicinal benefits and a low risk for abuse.

See Story at CNN


Already awash in legal marijuana, Denver endorses psilocybin as a mind-altering option

Voters in Denver approved the nation’s first referendum on decriminalizing hallucinogenic mushrooms Tuesday. Though it took election officials until Wednesday afternoon to tabulate the vote, 50.6 percent of the 176,000 voters picked “yes,” and 49.4 percent voted no.

The voters endorsed a change in Denver law that will require police to make arresting people for personal possession or use of psilocybin mushrooms “the lowest law enforcement priority in the City and County of Denver.” The final vote total still must be certified by Denver election officials.

“We’re sending a clear signal to the rest of the country,” Kevin Matthews, the leader of the “Decriminalize Denver” movement, which placed Initiative 301 on the ballot, said. “that America is ready to talk about psilocybin. We have work to do, we’re ready for it and we couldn’t be happier.”

In early returns, it appeared the measure might not pass. City residents had three weeks to cast votes, and a large number of votes submitted on Tuesday enabled the yes votes to reverse a 4,700-vote deficit in the final count.

Although recreational marijuana is now legal in Colorado, the mushroom referendum affected only Denver. Hallucinogenic mushrooms remain illegal in Denver and the rest of Colorado, and selling them will still be a felony. They also remain a Schedule I controlled substance under federal law. Matthews said they would not have been available in the city’s cannabis dispensaries and should still be used carefully.

The initiative also establishes a review panel to analyze the public safety, administrative, fiscal and health impacts of the decriminalization of mushrooms.

Denver’s law enforcement community was not thrilled by the prospect of more readily available hallucinogens. The Denver Police Department declined to comment. A spokeswoman for Denver Mayor Michael Hancock (D), who was leading in his bid for a third term in a race that was still undecided Wednesday, said he opposed the initiative, and Denver District Attorney Beth McCann (D) also voiced opposition.

Kevin Matthews led the campaign for magic mushrooms in Denver, called “Decriminalize Denver.” (Hyoung Chang/DP)

“We’re still figuring out marijuana, and even though things are going well so far, we’re still measuring the impacts on the people of Denver,” McCann said. She said she feared that, if the measure passed, Denver would attract more drug users and mushroom-influenced drivers would create havoc.

After the measure passed, McCann’s spokeswoman, Carolyn Tyler, said the prosecutor supported the review committee created by the referendum and “we’ll study how it’s going to affect the city.” Tyler noted that “the language in the initiative is open-ended and it will take us some time to implement next steps,” including figuring out how a section about not funding prosecution of mushroom cases would be interpreted. Tyler said the measure would not change much in the district attorney’s office because “we are not putting people in jail for low-level possession.”

But a number of studies have shown that psilocybin can have positive, lasting effects on depression, chronic pain, post-traumatic stress disorder, addictions and anxiety. Matthews said his own experience with mushrooms had helped him overcome major depression.

The federal Food and Drug Administration has granted “breakthrough therapy” status to study psilocybin for treating depression. The FDA describes breakthrough therapy as designed to expedite development of a drug after preliminary evidence shows “the drug may demonstrate substantial improvement over available therapy.”

Matthews said psilocybin has been shown to help reduce dependence on opioids. “Given our national crisis with opioids, that’s a big one,” he said. He also noted that a large, and rising, percentage of the American populace is taking medication for mental health. “It’s pretty clear” from the FDA granting psilocybin “breakthrough status,” Matthews said, “that the federal government knows we need some other solutions as well.”

The Denver Psilocybin Initiative raised about $45,000 in support of the campaign, advertising mostly on social media and posters around Denver, and it gathered more than 9,000 signatures to get Initiative 301 on the ballot. There was no organized opposition.

Early totals on Tuesday night had the mushroom referendum trailing by as much as 55 percent to 45 percent, but by 1 a.m., the margin had narrowed to about three percentage points. The final total was released about 4:30 p.m. Mountain time.

“What an amazing 22 hours,” Matthews said. “We’re really looking forward to creating a positive relationship with city officials in Denver and working with and educating Denver residents, and being part of the continuing conversation.”

“No one should be arrested or incarcerated simply for using or possessing psilocybin or any other drug,” said Art Way, Colorado State Director of the Drug Policy Alliance. ““If anything, this initiative doesn’t go nearly far enough. Given the scientific and public support for decriminalizing all drugs, as Portugal has done successfully, we need broader reforms that can scale back the mass criminalization of people who use drugs.”

Washington Post – Magic Mushroom Vote Denver


Published Wednesday, May 8, 2019 5:04PM EDT 

Health Canada has granted more special exemptions to religious groups in Ontario and Quebec to import a controversial hallucinogenic brew.

The agency has so far allowed five groups to use ayahuasca, a brew with psychoactive ingredients, without the fear of legal repercussions.

The first two ayahuasca exemptions were granted to groups in Montreal in 2017 — the Eclectic Centre for the Universal Flowing Light, also known as Céu do Montréal, and the Beneficient Spiritist Center União do Vegetal.

Three more exemptions were granted to the Ceu da Divina Luz do Montreal in May 2018, the Église Santo Daime Céu do Vale de Vida in Val-David, Que. in December 2018 and the Ceu de Toronto in November 2018.

The exemptions are valid for two years and are renewable.

Ayahuasca is otherwise illegal in Canada because it contains prohibited hallucinogens dimethyltryptamine (DMT) and harmaline.

“These exemptions provide these applicant’s designated members, senior members and registrants with the authority to possess, provide, transport, import, administer and destroy Daime Tea (ayahuasca), as applicable, when carrying out activities related to their religious practice, subject to the terms and conditions of the exemption,” Health Canada spokesperson Maryse Durette told

Canada’s federal health agency has the ability to exempt people and substances from aspects of the Controlled Drugs and Substances Act for medical, scientific or public interest purposes.

Details of the exemptions, such as policies and procedures related to the use of Daime tea, are private and confidential to the applicants, Durette said.

Ayahuasca has been used by indigenous people in south America for centuries as a sacrament in shamanic ceremonies.

The ceremony is usually accompanied by purging, which includes vomiting and diarrhea, which is believed to release built-up emotions and negative energy.

Some mental health professionals believe the drink could have benefits in treating depression or addiction under strict controls.

Ayahuasca ceremonies have become popular with tourists in Peru, where it is legal.

Over the past decade at least 11 tourists have been killed in incidents linked to traditional medicine in South America, according to news reports.

In a study published in August 2018 in the journal Frontiers, 13 volunteers took dimethyltryptamine, or DMT, the naturally occurring psychedelic that is the primary ingredient in ayahuasca.

Most volunteers confirmed seeing or being surrounded by a brilliant light, mirroring reports of so-called near-death experiences in which people claim they felt a sense of inner peace and an out-of-body sensation of passing into another realm.

Most study volunteers said they were engulfed in a sensation of warmth and felt a vibration in their bodies. Others reported encountering foreign entities with a sense of emotion and gratitude.

CTV News



Retailers across Canada are struggling with a shortage of all cannabis, but there’s one product they’re especially desperate to keep on shelves: cannabidiol or CBD, a non-intoxicating extract vaunted for its purported health benefits.

The extract, most commonly sold as oil, has been promoted as a natural cure for pain, anxiety and insomnia, despite limited medical research. Many customers are coming in asking for it, especially first-time and older users, store owners say.

“I don’t think the licensed producers really realized how popular CBD was, so there’s none available, really,” said Krystian Wetulani, founder of City Cannabis Co. in Vancouver.

“When something becomes available on the cannabis wholesale ordering sheet, everybody tries to get all that’s available. It’s like a race. That’s one of the biggest opportunities we’re facing in the legalized market.”

Companies are ramping up hemp growth to produce the trendy extract, but observers expect the shortage to persist until late this year. Meanwhile, scientists are working to separate the hype from reality when it comes to medical claims about the drug.

While licensed producers were preparing for legalization last year, they assumed most of the demand was going to be for cannabis high in THC, the intoxicating ingredient, said Khurram Malik, CEO of Biome Grow.

The buzz around CBD grew with the passage last year of a U.S. law known as the farm bill, which allows for the growing of hemp for the purposes of extracting cannabidiol, he said. Similar regulations came into effect in Canada in October.

But it was the U.S. law that drove up media coverage and social-media influencer chatter, Malik said. Kim Kardashian West recently posted on Instagram about her “CBD baby shower,” where she invited guests to make cannabidiol-infused salt scrubs and body oil.

“Because of the farm bill passing, the sexiness or the in-vogue profile of CBD went through the roof,” said Malik. “The demand side just blew up and caught everyone by surprise, on both sides of the border.”

Chef Travis Petersen adds THC distillate to geoduck crudo dishes during a multi-course cannabis-infused meal in Vancouver last year. The 34-year-old former MasterChef Canada contestant will then dose the forthcoming multi-course dinner with the appropriate amount of THC and CBD. (Darryl Dyck/The Canadian Press)

Extracting CBD from hemp, which is low-THC and high-CBD, is more affordable because the crop can be grown outdoors on a large scale under Canadian rules that are less restrictive than those for producing high-THC marijuana, Malik said.

Biome Grow has partnered with CBD Acres, which Malik said will supply his company with up to 20,000 kilograms of cannabidiol concentrate annually in order to serve Canadian and international markets.

The CBD shortage affects jurisdictions across Canada, said provincial distributors in British Columbia, Nova Scotia, and Newfoundland and Labrador.

“There has been a significant learning curve for licensed producers as they transition into supplying a new market,” said B.C.’s Liquor Distribution Branch in a statement. “Licensed producers are working towards becoming more efficient, however many of their expansion projects have not yet been fully ramped up.”


The branch added it expects supply to increase in the second half of 2019 as expansions come online and more producers receive licences to enter the marketplace.

Beverley Ware, a spokesperson for the Nova Scotia Liquor Corp., said while it has “CBD-leaning” products, it has not been able to consistently carry pure CBD oil due to the national shortage.

Customers looking for CBD products would prefer not to smoke them and don’t want the added THC, said Darrell Smith, spokesperson for the Newfoundland and Labrador Liquor Corp.

“It has been a challenge to source a steady supply of these products as they are often reserved for the medical cannabis community,” he said.


Despite the hype, research into the health benefits of cannabidiol has been fairly limited, said Dr. Gabriella Gobbi, a psychiatrist at McGill University who has studied the drug.

Gobbi’s team published a study in the journal Pain last October that pinpointed the effective dose of CBD for safe relief of pain and anxiety. The U.S. Food and Drug Administration has also approved a CBD drug to treat children with severe epilepsy.

But more research is still needed, particularly on CBD’s effects on anxiety and insomnia, Gobbi said.

Some patients who try it experience no effects and studies have also indicated a placebo effect in some people with anxiety, depression and pain, she added.

“Today there is a dominant culture of cannabis, a dominant culture of everything that is natural is good. This is why … cannabidiol is so popular.”

CBC- CBD Shortage


Hi folks, it’s Mike Smith/Bubbles from the Netflix series ‘Trailer Park Boys’ here. I’m starting this GoFundMe campaign for a long time Trailer Park Boys fan, and now our friend, Tom Termeer.

Tom is from London, Ontario, Canada and he suffers from what a lot of doctors refer to as ‘the most painful disease known to science – Trigeminal Autonomic Cephalgia, or more commonly known as the Cluster Headache, or ‘Suicide Headache’. It’s a very rare condition that affects .01% of the worlds population, but it is aptly nicknamed the suicide headache because the pain can be so intense that, in many cases, people afflicted by it simply aren’t able to withstand the pain, and take their own lives to escape it.

And if you watch the video below, you can begin to understand why.  Since 2005, Tom has been suffering from the chronic version of this disease, which means he endures this excruciating pain on a daily basis, often multiple times a day, for anywhere between 30 minutes to 3 hours, per attack. Just take a minute to think about that. Every. Single. Day. Multiple times. Since 2005.  Since getting to know Tom better over the past several months he’s been truly inspiring to me.

During the precious moments he has where he isn’t suffering through one of these horrendous episodes, he uses that time to help the people around him, including working tirelessly to help the homeless. Meeting him, talking to him, and seeing first hand not only what he endures on a daily basis, but seeing the lengths he goes to help other people, despite his own condition, has been a truly humbling experience.

There is no known cure for this disease. BUT there is a clinic in NY that I’ve arranged to send Tom and his wife to, that is going to perform a promising new stem cell procedure on him, which hopefully will give him some much needed relief and healing. He deserves this chance to have any amount of improvement for his quality of life. Every penny I raise from this page is going directly to Tom’s treatment and any follow ups that we can arrange.

I’ve also setup a page at: where, if you haven’t seen it yet, you can pay to have celebrities record you a personalized shoutout.  I thought this might be a fun way to give something back to you hardcore Trailer Park Boys who wanna donate, so every penny I raise from selling cameos will also go to Tom’s treatment. On behalf of myself, and Tom, thanks for taking the time to read this and for anything you’re able to contribute! Every dollar counts!! Bubbles 😎

GoFundMe – Bubbles